Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ·Healthcare·Biotechnology
$40.95
-0.07%
Mkt Cap $5.23B
Analyst Ratings
No recent rating data.
Price Target (43 analysts)
$33.50
Range $19.00 – $52.00
Implied Upside
-18.2%
Consensus $33.50 vs current $40.95
NASDAQ·Healthcare·Biotechnology
$40.95
-0.07%
Mkt Cap $5.23B
No recent rating data.
Price Target (43 analysts)
$33.50
Range $19.00 – $52.00
-18.2%
Consensus $33.50 vs current $40.95